Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

Vizionfocus Inc. (4771.TW)

Compare
211.50
+1.50
+(0.71%)
At close: April 2 at 1:30:05 PM GMT+8
Loading Chart for 4771.TW
  • Previous Close 210.00
  • Open 210.00
  • Bid 211.50 x --
  • Ask 212.00 x --
  • Day's Range 208.00 - 214.00
  • 52 Week Range 153.50 - 354.00
  • Volume 200,819
  • Avg. Volume 163,983
  • Market Cap (intraday) 12.251B
  • Beta (5Y Monthly) 1.12
  • PE Ratio (TTM) 18.22
  • EPS (TTM) 11.61
  • Earnings Date --
  • Forward Dividend & Yield 3.24 (1.53%)
  • Ex-Dividend Date Jul 10, 2024
  • 1y Target Est 234.50

Vizionfocus Inc. engages in the manufacturing of medical equipment in Taiwan, China, Japan, and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, development, production, and wholesale of contact lenses. The company was founded in 2011 and is based in Miaoli, Taiwan.

www.vizionfocus.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4771.TW

View More

Performance Overview: 4771.TW

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4771.TW
25.52%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.54%

1-Year Return

4771.TW
40.46%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.06%

3-Year Return

4771.TW
31.88%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
20.84%

5-Year Return

4771.TW
31.88%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
120.40%

Compare To: 4771.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4771.TW

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    12.25B

  • Enterprise Value

    12.15B

  • Trailing P/E

    18.22

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.06

  • Price/Book (mrq)

    3.47

  • Enterprise Value/Revenue

    4.05

  • Enterprise Value/EBITDA

    9.32

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.30%

  • Return on Assets (ttm)

    10.67%

  • Return on Equity (ttm)

    24.77%

  • Revenue (ttm)

    3B

  • Net Income Avi to Common (ttm)

    669.59M

  • Diluted EPS (ttm)

    11.61

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.43B

  • Total Debt/Equity (mrq)

    34.68%

  • Levered Free Cash Flow (ttm)

    -64.97M

Research Analysis: 4771.TW

View More

Company Insights: 4771.TW

Research Reports: 4771.TW

View More

People Also Watch